Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma. (Q52619511)

4 May 2018

title

Strong expression of CXCL12 is associated with a favorable outcome in osteosarcoma. (English)

1 reference

4 May 2018

author

Jan Smida

2

1 reference

4 May 2018

Michael Rosemann

4

1 reference

4 May 2018

Michael J Atkinson

5

1 reference

4 May 2018

author name string

Daniel Baumhoer

1

1 reference

4 May 2018

Stephanie Zillmer

3

1 reference

4 May 2018

Peter J Nelson

6

1 reference

4 May 2018

Gernot Jundt

7

1 reference

4 May 2018

Irene von Luettichau

8

1 reference

4 May 2018

Michaela Nathrath

9

1 reference

4 May 2018

publication date

16 December 2011

1 reference

4 May 2018

published in

Modern Pathology

1 reference

4 May 2018

volume

25

1 reference

4 May 2018

issue

4

1 reference

4 May 2018

page(s)

522-528

1 reference

4 May 2018

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

cites work

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Cancer and the chemokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Stromal cell-derived factor-1/CXCR4 enhanced motility of human osteosarcoma cells involves MEK1/2, ERK and NF-kappaB-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Mutual, reciprocal SDF-1/CXCR4 interactions between hematopoietic and bone marrow stromal cells regulate human stem cell migration and development in NOD/SCID chimeric mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

A complex pattern of chemokine receptor expression is seen in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Elevated expression of CXC chemokines in pediatric osteosarcoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

CXCL12 (SDF-1)/CXCR4 pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

Conditional inactivation of the CXCR4 receptor in osteoprecursors reduces postnatal bone formation due to impaired osteoblast development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia cells into the peripheral blood and inhibit engraftment

1 reference

https://api.crossref.org/works/10.1038/MODPATHOL.2011.193

7 January 2021

10.1038/MODPATHOL.2011.193

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018